⌘K

Login Start Free

Home/Filings/4/0001415889-25-023899

4//SEC Filing

Hopman Mark 4

Accession 0001415889-25-023899

CIK 0001674632other

View on SEC.gov Company Profile

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 6:15 PM ET

Size

18.2 KB

Accession

0001415889-25-023899

Insider Transaction Report

Form 4

Period: 2025-09-04

Beta Bionics, Inc.BBNX

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2025-09-04$5.10/sh+4,093$20,874→ 38,033 total
Exercise/Conversion
Common Stock
2025-09-05$5.10/sh+11,411$58,196→ 42,626 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-05−11,411→ 21,725 total
Exercise: $5.10Exp: 2033-09-13→ Common Stock (11,411 underlying)
Exercise/Conversion
Common Stock
2025-09-04$5.10/sh+656$3,346→ 33,940 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-04−656→ 66,428 total
Exercise: $5.10Exp: 2033-07-26→ Common Stock (656 underlying)
Sale
Common Stock
2025-09-04$19.97/sh−6,818$136,180→ 31,215 total
Sale
Common Stock
2025-09-05$20.56/sh−11,411$234,657→ 31,215 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-04−4,093→ 33,136 total
Exercise: $5.10Exp: 2033-09-13→ Common Stock (4,093 underlying)

Footnotes (5)

[F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.
[F2]The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
[F3]The weighted average sale price for the transaction reported was $20.564162 and the range of prices were between $20.29 and $20.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
[F4]One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
[F5]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

Documents

1 file

4
form4-09082025_060903.xmlPrimary

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1

filerCIK 0002048497

Filing Metadata

Form type: 4
Filed: Sep 7, 8:00 PM ET
Accepted: Sep 8, 6:15 PM ET
Size: 18.2 KB

View on SEC.gov